首页> 外国专利> process for the manufacture of an indole alkaloid and its salt and its application as medicine

process for the manufacture of an indole alkaloid and its salt and its application as medicine

机译:吲哚生物碱及其盐的制备方法及其在医学中的应用

摘要

1350869 Salts based on descarbomethoxy dihydrovabasine AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE 13 March 1972 [12 March 1971] 11600/72 Heading C2C Novel salts of a compound I with a mineral or organic acid are prepared by extraction of the total alkaloids of dried root barks of Hazunta silicicola Pich with ether, methylene chloride or CHCl 3 , chromatography of the mixture on alumina, elution and conventional treatment of the appropriate fractions to give the required salts. Alternatively the dried root barks may be made alkaline and extracted with ether methylene chloride or CHCl 3 ; the extract is then concentrated and extracted with 10% aqueous sulphamic acid or 2-5% aqueous sulphuric acid; the acid solution is washed with ether, made alkaline with NH 3 and the precipitated alkaloids extracted with ether, methylene chloride or CHCl 3 ; the extract is chromatographed on alumina and eluted with benzene; and the resulting mixture of descarbomethoxyvobasine and descarbomethoxydihydrovobasine (I) is recrystallized from methanol, followed by salt formation. The hydrochloride of I may be prepared by dissolution of the dried root barks in methanol; addition of HCl until a pH of about 1 is obtained, and recrystallization of the crystals formed from methanol. Pharmaceutical compositions comprise a salt of I together with a suitable carrier or diluent and are administered in the form of tablets, pills, capsules, solutes, emulsions, syrups or suppositories. They are useful in treating hypertension, progressive cerebral insufficiency, vertigo, earbuzzing, disorders of memory, chronic cerebrosclerosis and disorders of consciousness of cranium traumatisms.
机译:1350869基于去甲氧甲氧基二氢缬氨酸的盐摄于1972年3月13日,加利福尼亚州拉瓦尔赫瓦涅丁国家级评估局[1971年3月12日] 11600/72标题C2C通过萃取干根皮的总生物碱制备化合物I与无机酸或有机酸的新盐。用醚,二氯甲烷或CHCl 3萃取Hazunta silicicola Pich,在氧化铝上对混合物进行色谱分离,洗脱,以及适当馏分的常规处理,得到所需的盐。或者,可以将干燥的根皮制成碱性,并用乙醚,二氯甲烷或CHCl 3萃取。然后浓缩萃取液,并用10%氨基磺酸水溶液或2-5%硫酸水溶液萃取;酸溶液用乙醚洗涤,用NH 3碱化,沉淀的生物碱用乙醚,二氯甲烷或CHCl 3萃取。萃取液在氧化铝上进行色谱分离,并用苯洗脱。然后将所得的去甲氧甲氧基vobasine和去甲氧甲氧基二氢vobasine(I)的混合物从甲醇中重结晶,然后形成盐。 I的盐酸盐可以通过将干燥的根皮溶解在甲醇中来制备。加入HCl直至获得约1的pH,并使由甲醇形成的晶体重结晶。药物组合物包含I的盐以及合适的载体或稀释剂,并且以片剂,丸剂,胶囊剂,溶质,乳剂,糖浆剂或栓剂的形式给药。它们可用于治疗高血压,进行性脑供血不足,眩晕,耳鸣,记忆障碍,慢性脑硬化和颅骨创伤性意识障碍。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号